Glympse Bio logo

Glympse Bio

Glympse Bio is developing a powerful new paradigm in diagnostics to enable noninvasive and predictive monitoring of multiple human diseases.

5

Funding Rounds

$94.3m

Money raised

Overview

Glympse Bio is developing a powerful new paradigm in diagnostics to enable noninvasive and predictive monitoring of multiple human diseases.

Funding

Funding series

Funding Series Analysis

The company Glympse Bio has raised a total of $27.3m in funding over 5 rounds.

Key Insights:

  • Glympse Bio Funding Round, December 2021: $18m
  • Glympse Bio Venture round, May 2020: $2.7m
  • Glympse Bio Seed round, December 2015: $6.6m
  • Glympse Bio, Inc. funding round, June 2020: $45m
  • Glympse Bio Inc funding round, October 2018: $22m
Glympse Bio logo
Glympse Bio Funding Round, December 2021 $18m
Glympse Bio logo
Glympse Bio Venture round, May 2020 $2.7m
Glympse Bio logo
Glympse Bio Seed round, December 2015 $6.6m
Glympse Bio logo
Glympse Bio Inc funding round, October 2018 $22m
Glympse Bio logo
Glympse Bio, Inc. funding round, June 2020 $45m